Carlos Almonacid

The impact of COVID-19 on patients with asthma

José Luís Izquierdo, Carlos Almonacid, Yolanda González et al. · European Respiratory Journal · 2020 · 230 citations · Full text

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma

Charles Pilette, Giorgio Walter Canonica, Rekha Chaudhuri et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 94 citations · Full text

Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

Luís Pérez de Llano, Ignacio Dávila, Eva Martínez-Moragón et al. · The Journal of Allergy and Clinical Immunology In Practice · 2021 · 47 citations · Full text

Asthma, Inflammatory Lung Disease, Lung Inflammation +8

Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors

José Luís Izquierdo Alonso, Pilar Resano, Abdulkader El Hechem et al. · International Journal of COPD · 2014 · 39 citations · Full text

Antifibrotic Therapy, Surgical Oncology, Advanced Lung Disease +16